Texas Neurology, P.A.
Welcome,         Profile    Billing    Logout  
 16 Trials 
28 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wymer, James
NCT04220021: Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Active, not recruiting
2
18
US
Metformin, Metformin hydrochloride sustained-release (SR)
University of Florida, ALS Association
C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia
08/24
06/25
NCT06735014: Multicenter ALS Imaging Study

Recruiting
N/A
90
US
Magnetic Resonance Imaging, Plasma neurofilament light chain (NfL) quantification
University of Minnesota, Food and Drug Administration (FDA), Minnesota Office of Higher Education
Amyotrophic Lateral Sclerosis, ALS
08/27
08/28
NCT05966038: ALS/MND Natural History Study Data Repository

Recruiting
N/A
5000
Europe, US
Massachusetts General Hospital, Henry Ford Health System, Northwestern University, Temple University, St. Louis University, University of Florida, University of Minnesota, Virginia Commonwealth University, Fondazione Serena Onlus - Centro Clinico NeMO Milano, Providence Health & Services, University of Pittsburgh, Istituti Clinici Scientifici Maugeri SpA
ALS, PLS, MND (Motor Neurone DIsease), Kennedy Disease, PMA - Progressive Muscular Atrophy, PBP - Progressive Bulbar Palsy
12/30
12/30
Plowman, Emily K
NCT04220021: Safety and Therapeutic Potential of the FDA-approved Drug Metformin for C9orf72 ALS/FTD

Active, not recruiting
2
18
US
Metformin, Metformin hydrochloride sustained-release (SR)
University of Florida, ALS Association
C9orf72 Amyotrophic Lateral Sclerosis (ALS), Frontotemporal Dementia
08/24
06/25
NCT04887415: Respiratory Strength Training in Cardiac Surgical Patients

Completed
N/A
25
US
Respiratory Strength Training (RST) Program
University of Florida, American Speech-Language-Hearing Foundation, American Heart Association
Cardiovascular Diseases, Thoracic Diseases, Surgery, Surgery--Complications, Dysphagia
01/23
01/23
NCT02962050: Delineating Swallowing Impairment and Decline in ALS

Completed
N/A
109
US
Videofluoroscopic Swallowing Study (VFSS), VFSS, X-Ray of Swallowing, Modified Barium Swallow Study, Voluntary Peak Cough Flow Testing, Iowa Oral Performance Instrument, IOPI, Capsaicin Challenge, Reflexive Cough Testing, Pulmonary Function Testing, Eating Assessment Tool 10, EAT 10, The Center for Neurologic Study Bulbar Function Scale, CNS-BFS
University of Florida, National Institute of Neurological Disorders and Stroke (NINDS)
Amyotrophic Lateral Sclerosis
02/23
02/23
NCT04464317: Dysphagia and Vocal Cord Injury Following Cardiac Surgery

Withdrawn
N/A
6000
NA
University of Florida
Dysphagia, Cardiovascular Diseases
06/23
06/23
NCT04773184: Improving Diagnostic Standards in Dysphagia

Completed
N/A
46
US
Fiberoptic Endoscopic Evaluation of Swallowing, (FEES), Videofluoroscopic Swallowing Study, Voluntary Peak Cough Flow Testing, Iowa Oral Performance Instrument, Capsaicin Challenge, Reflexive Cough Testing, Pulmonary Function Testing, Voicing Tasks
University of Florida
Dysphagia
09/23
09/23
NCT05304416: Clinical Markers of Dysphagia in Cardiac Surgical Patients

Active, not recruiting
N/A
347
US
Fiberoptic Endoscopic Evaluation of Swallowing, FEES, Simultaneous FEES and Videofluoroscopy instrumental swallowing exam, Endofluoroscopy, Videofluoroscopy instrumental swallowing exam (VFSS), Modified barium swallow study, Voluntary Cough Peak Expiratory Flow (PEF) Testing, Reflex Cough Screen, Lingual Pressure Testing, Speech Testing
University of Florida, National Institute of Nursing Research (NINR), Ohio State University
Cardiovascular Diseases, Dysphagia
10/26
12/26
NIA_RV, NCT05497219: Reference Values for Videofluoroscopic Measures of Swallowing

Enrolling by invitation
N/A
580
Canada, US
Videofluoroscopic Swallowing Study (VF)
University Health Network, Toronto, University of Florida, McMaster University, National Institute on Aging (NIA), Ohio State University
Dysphagia, Oropharyngeal
11/26
07/27
Morgan, Todd M
BRIDGE, NCT05538663: Intravesical BCG vs GEMDOCE in NMIBC

Recruiting
3
870
US
Gemcitabine, GEMZAR, Docetaxel, Taxotere, Bacillus Calmette Guerin, BCG
ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI)
Non-muscle-invasive Bladder Cancer
11/29
10/30
GUNS, NCT04812366: Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Recruiting
2
315
Canada, US
Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab, Docetaxel, Niraparib 100mg Oral Capsule, Atezolizumab
University of British Columbia, Janssen Inc., University Health Network, Toronto
Prostate Cancer
04/26
04/26
BRCAAway, NCT03012321: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Active, not recruiting
2
70
US
Olaparib, Lynparza, Abiraterone Acetate, Prednisone
Northwestern University, AstraZeneca, National Cancer Institute (NCI)
Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer
12/26
01/27
G-MINOR, NCT02783950: Genomics in Michigan Impacting Observation or Radiation

Completed
N/A
356
US
Decipher Prostate Cancer Classifier, Decipher Post-Op
University of Michigan Rogel Cancer Center, Michigan Urological Surgery Improvement Collaborative (MUSIC), GenomeDx Biosciences Corp
Prostate Cancer
02/20
04/24
NCT04396808: Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer

Recruiting
N/A
900
US
Decipher, Decipher Prostate Cancer Classifier, Prolaris, Prolaris Prostate Cancer Test, Oncotype Dx Genomic Prostate Score (GPS), Standard of care (askMUSIC score), askMUSIC score
University of Michigan Rogel Cancer Center, National Institutes of Health (NIH), Myrexis Inc., Veracyte, Inc., MDx Health
Prostate Cancer
07/25
07/25
PASS, NCT00756665: Prostate Active Surveillance Study

Recruiting
N/A
3000
Canada, US
University of Washington, Canary Foundation, Early Detection Research Network
Prostatic Neoplasms
09/29
09/32
TARGET-HCC, NCT02954094: A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

Recruiting
N/A
10000
Europe, US
Target PharmaSolutions, Inc.
Hepatocellular Cancer
10/25
10/25
NCT03692897: An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection

Recruiting
N/A
5000
Canada, US
All approved therapies for the treatment of Chronic Hepatitis B (CHB)
Target PharmaSolutions, Inc.
Hepatitis B, Hepatitis, Liver Diseases
01/26
01/26
Heitzman, Daragh
COURAGE-ALS, NCT04944784 / 2020-004040-29: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Terminated
3
489
Europe, Canada, US, RoW
Reldesemtiv, Placebo
Cytokinetics
Amyotrophic Lateral Sclerosis
07/23
07/23
COURAGE OLE, NCT05442775 / 2021-004727-33: A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)

Terminated
3
71
Europe, Canada, US, RoW
Reldesemtiv
Cytokinetics, Cytokinetics Inc
Amyotrophic Lateral Sclerosis
06/23
06/23
NCT06450886: Long-term Extension Study of Ulviprubart (ABC008) in Subjects with Inclusion Body Myositis

Active, not recruiting
2/3
270
US, RoW
Ulviprubart (ABC008)
Abcuro, Inc.
Inclusion Body Myositis (IBM)
01/29
04/29
NCT05721573: A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Active, not recruiting
2/3
231
Europe, Canada, US, RoW
ABC008
Abcuro, Inc., Syneos Health
Inclusion Body Myositis
11/25
12/25
NCT06408727: Intermediate Expanded Access Protocol CNMAu8.EAP04

Available
N/A
US
CNM-Au8
Clene Nanomedicine, National Institute of Neurological Disorders and Stroke (NINDS)
ALS, Amyotrophic Lateral Sclerosis, PALS
 
 
NCT05597436: Intermediate-Sized Expanded Access Study

No Longer Available
N/A
US
Trehalose, SLS-005 Intravenous Trehalose Injection 90.5 mg/mL
Seelos Therapeutics, Inc., Massachusetts General Hospital, National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)
Amyotrophic Lateral Sclerosis
 
 
CNMAu8.EAP02, NCT05281484: Two Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01 and for ALS

Available
N/A
US
CNM-Au8, Nanocrystalline gold
Clene Nanomedicine
Amyotrophic Lateral Sclerosis
 
 
Bhai, Salman
ALKIVIA, NCT05523167 / 2021-001277-23: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants with Active Idiopathic Inflammatory Myopathy.

Recruiting
2/3
240
Europe, Canada, Japan, US, RoW
EFG PH20 SC, PBO
argenx, argenx BV
Active Idiopathic Inflammatory Myopathy, Myositis, Dermatomyositis, Polymyositis, Immune-Mediated Necrotizing Myopathy, Antisynthetase Syndrome
12/26
02/27
STRIDE, NCT04535609 / 2020-002855-40: An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients

Completed
2
213
Europe, Canada, US, RoW
Mavodelpar, REN001, Placebo
Reneo Pharma Ltd
Primary Mitochondrial Myopathy
09/23
10/23
MOVE FSHD, NCT04635891: Motor Outcomes to Validate Evaluations in FSHD

Recruiting
N/A
450
Europe, Canada, US
University of Kansas Medical Center, FSHD Society, Inc., Friends Research Institute, Inc., University of Rochester, University of Nevada, Reno, FSHD Canada, Avidity Biosciences, Inc., AMRA Medical, Seattle Children's Hospital, Dyne Therapeutics, Hoffmann-La Roche
FSHD
12/26
01/27

Download Options